Article

Efficacy and Mechanism of Panax Notoginseng in the Secondary Prevention for Stroke Patients with "Antiplatelet Drug Resistance"

2021-10-18

Abstract excerpt

<h4>Background: </h4> Cerebral stroke is common and associated with high rates of mortality, disability, and recurrence while the chance of complete recovery is low. It adversely affects human physical and mental health and represents the leading cause of death in China. Aspirin is the cornerstone of secondary prevention of cerebral stroke. However, recurrence of stroke cannot be completely prevented by regular or...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 081f8392-c554-56f0-b732-a14ad42cc7df
DOI: 10.21203/rs.3.rs-649760/v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Efficacy and Mechanism of Panax Notoginseng in the Secondary Prevention for Stroke Patients with "Antiplatelet Drug Resistance"DOI 10.21203/rs.3.rs-649760/v1Read

Short-term efficacy and safety of personalized antiplatelet therapy for patients with acute ischaemic stroke or transient ischaemic attack: A randomized clinical trial.Semantic proximity Read

Model based on single-nucleotide polymorphism to discriminate aspirin resistance patients.Semantic proximity Read

Exploring the Therapeutic Efficacy and Pharmacological Mechanism of Guizhi Fuling Pills on Ischemic Stroke: A Meta-Analysis and Network Pharmacology AnalysisSemantic proximity Read

Effect of precision antiplatelet therapy based on CYP2C19/11-dhTxB2 variability in prognosis of ischemic stroke/TIA patients: study protocol for a multicenter randomized controlled trialSemantic proximity Read

Effect of pharmacogenomics - oriented Dual Antiplatelet Therapy Followed by P2Y12 receptor inhibitors/Aspirin on Cardiovascular and Bleeding Events in ACS Patients: A Trial ProtocolSemantic proximity Read

Clinical Evidence-Based Evaluation of ZFXNY in Treatment of Acute Cerebral InfarctionSemantic proximity Read

Associations of CYP3A4, NR1I2, CYP2C19 and P2RY12 polymorphisms with clopidogrel resistance in Chinese patients with ischemic stroke.Semantic proximity Read

A brief review on the mechanisms of aspirin resistance.Semantic proximity Read

Time Course for Benefit and Risk With Ticagrelor and Aspirin in Individuals With Acute Ischemic Stroke or Transient Ischemic Attack Who Carry CYP2C19 Loss-of-Function Alleles: A Secondary Analysis of the CHANCE-2 Randomized Clinical Trial.Semantic proximity Read

Dynamic changes and associated factors of clopidogrel resistance in patients after cerebral infarction.Semantic proximity Read

Guided antiplatelet therapy with P2Y12 antagonists in patients undergoing percutaneous coronary intervention: 3 systematic reviews with meta-analyses of randomized controlled trials with homogeneous designSemantic proximity Read

Clinical outcomes of generic versus brand-name clopidogrel for secondary prevention in patients with ischemic stroke: A nationwide retrospective cohort studySemantic proximity Read